Edwards Lifesciences (EW) Earnings Date, Estimates & Call Transcripts $70.96 +0.48 (+0.68%) (As of 08:20 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Edwards Lifesciences Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 4EstimatedActual EPS (Oct. 24) $0.67 Consensus EPS (Oct. 24) $0.67 Edwards Lifesciences posted Q3 2024 earnings on October 24, 2024, reporting an EPS of $0.67, which hit analysts' consensus estimates of $0.67. Quarterly revenue rose 8.9% year-over-year to $1.35 billion, below analyst estimates of $1.57 billion. With a trailing EPS of $6.93 and a P/E Ratio of 10.24, Edwards Lifesciences' earnings are expected to decrease -5.45% next year, from $2.57 to $2.43 per share. Conference Call TranscriptConference Call AudioEW Upcoming EarningsEdwards Lifesciences' next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules. Get Edwards Lifesciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edwards Lifesciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEW Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EW Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Darwin2025: Digital Asset Insights You Need to KnowCryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! Edwards Lifesciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$0.64$0.65$0.640.620 - 0.660Q2 20243$0.70$0.70$0.700.670 - 0.710Q3 20243$0.67$0.69$0.680.670 - 0.710Q4 20243$0.56$0.65$0.590.530 - 0.570FY 202412$2.57$2.69$2.61 Q1 20253$0.58$0.60$0.59 Q2 20253$0.61$0.63$0.62 Q3 20253$0.60$0.64$0.62 Q4 20253$0.63$0.64$0.64 FY 202512$2.42$2.51$2.47 Q1 20261$0.66$0.66$0.66 Q2 20261$0.69$0.69$0.69 Q3 20261$0.71$0.71$0.71 Edwards Lifesciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/4/2025(Estimated)------- 10/24/2024Q3 2024$0.67$0.67--$3.79$1.57B$1.35B 7/24/2024Q2 2024$0.69$0.70+$0.01$0.79$1.65B$1.63B 4/25/2024Q1 2024$0.64$0.66+$0.02$0.74$1.58B$1.60B 2/6/2024Q4 2023$0.64$0.64-$0.67$1.50B$1.53B 10/25/2023Q3 2023$0.59$0.59-$0.55$1.48B$1.48B 7/26/2023Q2 2023$0.65$0.66+$0.01$0.82$1.51B$1.53B “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide!4/26/2023Q1 2023$0.61$0.62+$0.01$0.68$1.39B$1.46B 1/31/2023Q4 2022$0.61$0.64+$0.03$0.63$1.33B$1.35B Edwards Lifesciences Earnings - Frequently Asked Questions When is Edwards Lifesciences's earnings date? Edwards Lifesciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on EW's earnings history. What guidance has Edwards Lifesciences issued on next quarter's earnings? Edwards Lifesciences updated its fourth quarter 2024 earnings guidance on Thursday, October, 24th. The company provided earnings per share guidance of 0.530-0.570 for the period, compared to the consensus EPS estimate of 0.620. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Did Edwards Lifesciences beat their earnings estimates last quarter? In the previous quarter, Edwards Lifesciences (NYSE:EW) reported $0.67 earnings per share (EPS) to hit the analysts' consensus estimate of $0.67. Learn more on analysts' earnings estimate vs. EW's actual earnings. How can I listen to Edwards Lifesciences's earnings conference call? The conference call for Edwards Lifesciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Edwards Lifesciences's conference call transcript? The conference call transcript for Edwards Lifesciences's latest earnings report can be read online. Read Transcript How much revenue does Edwards Lifesciences generate each year? Edwards Lifesciences (NYSE:EW) has a recorded annual revenue of $6.00 billion. How much profit does Edwards Lifesciences generate each year? Edwards Lifesciences (NYSE:EW) has a recorded net income of $1.40 billion. EW has generated $6.93 earnings per share over the last four quarters. What is Edwards Lifesciences's price-to-earnings ratio? Edwards Lifesciences (NYSE:EW) has a trailing price-to-earnings ratio of 10.14 and a forward price-to-earnings ratio of 27.35. The price/earnings-to-growth ratio is 3.96. What is Edwards Lifesciences's EPS forecast for next year? Edwards Lifesciences's earnings are expected to decrease from $2.57 per share to $2.43 per share in the next year, which is a -5.45% change. ` More Earnings Resources from MarketBeat Related Companies SYK Earnings Results BSX Earnings Results MDT Earnings Results BDX Earnings Results RMD Earnings Results IDXX Earnings Results DXCM Earnings Results STE Earnings Results PODD Earnings Results HOLX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report 2025: Digital Asset Insights You Need to Know (Ad)Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! This page (NYSE:EW) was last updated on 11/25/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
